NCT05724680 is a NA clinical trial of cognitive behavior therapy in Depression, sponsored by Rajshahi University.

Who is sponsoring NCT05724680?

NCT05724680 is sponsored by Rajshahi University.

What drugs are being tested in NCT05724680?

Interventions in NCT05724680: cognitive behavior therapy.

What condition does NCT05724680 study?

NCT05724680 studies Depression.

Is NCT05724680 still recruiting?

NCT05724680 is currently completed. Last updated 13 February 2023.

Last reviewed 2023-02-13 · How we verify

NCT05724680

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Effectiveness of Cognitive Behavior Therapy for Persons With Depression

Completed NA Last updated 13 February 2023

What this trial tests

NA trial testing cognitive behavior therapy in Depression in 148 participants. Completed in 30 May 2019.

Timeline

10 August 2018

Primary endpoint
10 May 2019

30 May 2019

Quick facts

Lead sponsor	Rajshahi University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	148
Start date	10 August 2018
Primary completion	10 May 2019
Estimated completion	30 May 2019
Sites	1 location across Bangladesh

Drugs / interventions tested

cognitive behavior therapy

Conditions studied

Depression — all drugs for Depression →

Sponsor

Rajshahi University

Who can join

Adults 18 to 60, any sex, with Depression. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This was a randomized controlled clinical trial (RCT) carried out in three different hospitals in Dhaka city, Bangladesh.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of cognitive behavior therapy

Trials testing the same drug.

NCT06942858 — Mechanisms of Deep Transcranial Magnetic Stimulation in Enhancing Cognitive-Behavioral Therapy for Anorexia Nervosa · NA · recruiting
NCT04610931 — Study of the Effectiveness of a Virtual Reality Treatment in the Management of Smoking Cessation · NA · completed
NCT04741308 — Cognitive Behavior Therapy (CBT) and Psychological Status and Immune Function · NA · unknown

Other recruiting trials for Depression

Currently open trials in the same condition.

NCT07336238 — Group Retreat Psilocybin Therapy for the Treatment of Anxiety and Depression in Patients With Metastatic Solid Tumors or · Phase 2 · recruiting
NCT06906939 — A Randomized Pilot rTMS Trial for Knee Arthritis Pain and Depression · EARLY_PHASE1 · recruiting
NCT07517549 — Sexual Health Education During Pregnancy · NA · recruiting
NCT06408246 — ACE-D Aim 3 Clinical Cognitive Trial to Enhance Translation in Depression · Phase 2 · recruiting
NCT07449676 — Effects of an Innovative TCM-based Tui Jing Therapy on Psychological and Neurophysiological Functions in Depression · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05724680 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Rajshahi University
Last refreshed: 13 February 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05724680.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing